<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Pharmacogenomics</journal-id>
<journal-id journal-id-type="iso-abbrev">Pharmacogenomics</journal-id>
<journal-id journal-id-type="publisher-id">PGS</journal-id>
<journal-title-group>
<journal-title>Pharmacogenomics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1462-2416</issn>
<issn pub-type="epub">1744-8042</issn>
<publisher>
<publisher-name>Future Medicine Ltd</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27633613</article-id>
<article-id pub-id-type="pmc">5558513</article-id>
<article-id pub-id-type="doi">10.2217/pgs-2016-0053</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Systematic Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pharmacogenetic research activity in Central America and the Caribbean: a systematic review</article-title>
<alt-title alt-title-type="running-head">Céspedes-Garro, Naranjo, Rodrigues-Soares <italic>et al.</italic></alt-title>
<alt-title alt-title-type="running-head">Pharmacogenetic research in Central America &amp; the Caribbean</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Céspedes-Garro</surname>
<given-names>Carolina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Naranjo</surname>
<given-names>María-Eugenia G</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rodrigues-Soares</surname>
<given-names>Fernanda</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>LLerena</surname>
<given-names>Adrián</given-names>
</name>
<xref ref-type="corresp" rid="C0001">*</xref>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duconge</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montané-Jaime</surname>
<given-names>Lazara K</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff6"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Roblejo</surname>
<given-names>Hilda</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fariñas</surname>
<given-names>Humberto</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Campos</surname>
<given-names>María de los A</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="aff" rid="aff8"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ramírez</surname>
<given-names>Ronald</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff9">
<sup>9</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff9"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Serrano</surname>
<given-names>Víctor</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff10">
<sup>10</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff10"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Villagrán</surname>
<given-names>Carmen I</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff11">
<sup>11</sup>
</xref>
<xref ref-type="aff" rid="aff2"></xref>
<xref ref-type="aff" rid="aff11"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peñas-LLedó</surname>
<given-names>Eva M</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff1"></xref>
<xref ref-type="aff" rid="aff2"></xref>
</contrib>
<aff id="aff1">
<label>1</label>CICAB Clinical Research Centre, Extremadura University Hospital &amp; Medical School, Badajoz, Spain</aff>
<aff id="aff2">
<label>2</label>RIBEF Ibero-American Network of Pharmacogenetics &amp; Pharmacogenomics</aff>
<aff id="aff3">
<label>3</label>Teaching &amp; Research Department, Genetics Section, School of Biology, University of Costa Rica, San José, Costa Rica</aff>
<aff id="aff4">
<label>4</label>Departamento de Biologia Geral, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil</aff>
<aff id="aff5">
<label>5</label>Pharmaceutical Sciences Department, School of Pharmacy, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico</aff>
<aff id="aff6">
<label>6</label>Pharmacology Unit Department of Paraclinical Sciences, Faculty of Medical Sciences, The University of West Indies, St Augustine, Trinidad &amp; Tobago</aff>
<aff id="aff7">
<label>7</label>Teaching &amp; Research Department, National Center of Medical Genetics, Havana, Cuba</aff>
<aff id="aff8">
<label>8</label>Secretaría Ejecutiva del Consejo de Ministros de Salud de Centroamérica y República Dominicana, Ciudad Merliot, El Salvador</aff>
<aff id="aff9">
<label>9</label>Facultad de Medicina, UNAN Universidad Autónoma Nacional de Nicaragua, León, Nicaragua</aff>
<aff id="aff10">
<label>10</label>CIIMET Centro de Investigación e Información de Medicamentos y Tóxicos, Facultad de Medicina, Universidad de Panamá, Panamá, Panamá</aff>
<aff id="aff11">
<label>11</label>Facultad de Ciencias Médicas, Dirección de Investigación, Universidad de San Carlos de Guatemala, Guatemala</aff>
</contrib-group>
<author-notes>
<corresp id="C0001">*Author for correspondence: <email xlink:href="mailto:allerena@unex.es">allerena@unex.es</email></corresp>
<fn fn-type="COI-statement">
<p>
<bold>Financial &amp; competing interests disclosure</bold>
</p>
<p>This study was supported by the University of Costa Rica (PhD fellowship to C Céspedes-Garro in Spain), Gobierno de Extremadura, Agencia Extremeña de Cooperación Internacional para el Desarrollo AEXCID 13IA001 (MESTIFAR; to Sociedad Iberoamericana de Farmacogenética y Farmacogenómica). This project has been coordinated in the network Red Iberoamericana de Farmacogenética y Farmacogenómica (<ext-link ext-link-type="uri" xlink:href="http://www.ribef.com">www.ribef.com</ext-link>) and MESTIFAR Project. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.</p>
<p>No writing assistance was utilized in the production of this manuscript.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>16</day>
<month>9</month>
<year>2016</year>
</pub-date>
<volume>17</volume>
<issue>15</issue>
<fpage>1707</fpage>
<lpage>1724</lpage>
<history>
<date date-type="received">
<day>24</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>7</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© 2016 Future Medicine Ltd</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<self-uri content-type="pdf" xlink:href="pgs-17-1707.pdf" xlink:type="simple"></self-uri>
<abstract>
<sec>
<title>Aim:</title>
<p>The present review was aimed at analyzing the pharmacogenetic scientific activity in Central America and the Caribbean.</p>
</sec>
<sec>
<title>Materials &amp; methods:</title>
<p>A literature search for pharmacogenetic studies in each country of the region was conducted on three databases using a list of the most relevant pharmacogenetic biomarkers including ‘phenotyping probe drugs’ for major drug metabolizing enzymes. The review included 132 papers involving 47 biomarkers and 35,079 subjects (11,129 healthy volunteers and 23,950 patients).</p>
</sec>
<sec>
<title>Results:</title>
<p>The country with the most intensive pharmacogenetic research was Costa Rica. The most studied medical therapeutic area was oncology, and the most investigated biomarkers were CYP2D6 and <italic>HLA-A/B</italic>.</p>
</sec>
<sec>
<title>Conclusion:</title>
<p>Research activity on pharmacogenetics in Central American and the Caribbean populations is limited or absent. Therefore, strategies to promote effective collaborations, and foster interregional initiatives and research efforts among countries from the region could help for the rational clinical implementation of pharmacogenetics and personalized medicine.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>biomarkers</kwd>
<kwd>Caribbean region</kwd>
<kwd>Central America</kwd>
<kwd>pharmacogenetics</kwd>
<kwd>pharmacogenomics</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>